Last reviewed · How we verify

NCT05428865

Correlation Between Body Mass Index, Selective Motor Control and Functional Ability in Children With CP

Completed Last updated 14 February 2023
What this trial tests

trial testing correlation study in Diplegic Cerebral Palsy in 84 participants. Completed in 24 July 2022.

Timeline
24 January 2022
Primary endpoint
1 June 2022
24 July 2022

Quick facts

Lead sponsorCairo University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment84
Start date24 January 2022
Primary completion1 June 2022
Estimated completion24 July 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 6 to 9, any sex, with Diplegic Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

PURPOSE: To investigate the correlations between body mass index, spasticity, functional ability and isolated motor control in children with spastic diplegia. BACKGROUND: Cerebral palsy is primarily a disorder of movement and posture HYPOTHESES: There is no correlation between body mass index, spasticity, functional ability and isolated motor control in children with spastic diplegia. RESEARCH QUESTION: Is there a correlation between body mass index, spasticity, functional ability and isolated motor control in children with spastic diplegia?

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Diplegic Cerebral Palsy

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05428865.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing